ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RUA Rua Life Sciences Plc

10.75
-0.75 (-6.52%)
08 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rua Life Sciences Plc LSE:RUA London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75 -6.52% 10.75 10.50 11.00 11.50 10.625 11.50 558,883 15:56:39
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 2.18M -2M -0.0323 -3.33 7.14M
Rua Life Sciences Plc is listed in the Plastics,resins,elastomers sector of the London Stock Exchange with ticker RUA. The last closing price for Rua Life Sciences was 11.50p. Over the last year, Rua Life Sciences shares have traded in a share price range of 8.65p to 58.50p.

Rua Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of Rua Life Sciences is £7.14 million. Rua Life Sciences has a price to earnings ratio (PE ratio) of -3.33.

Rua Life Sciences Share Discussion Threads

Showing 3726 to 3747 of 3775 messages
Chat Pages: 151  150  149  148  147  146  145  144  143  142  141  140  Older
DateSubjectAuthorDiscuss
17/10/2024
15:53
The Acquisition has not completed yet. Due Diligence being undertaken.
thiopia
17/10/2024
15:38
Can't understand this lack of support after the great acquisition made.
7767
17/10/2024
15:30
Can't understand this lack of support after the great acquisition made.
7767
11/10/2024
10:35
Can't see it being II interest buying right now as volume too small. Doesn't seem like they're keen on buyers though and reckon brakes will come off once someone pays 16p.
spawny100
11/10/2024
09:47
I'm expecting a bit of chop as a bit of supply comes onto the market as it moves up from here, but judging on past volumes in the next range, it doesn't look like it will be dragged back for too long as current demand is so strong and one way. It looks like professional (institutional) accumulation to me and long may it continue!
This is a different business now.

early not wrong
11/10/2024
08:02
The chart certainly looks nice, could move past 20p pretty quickly
davisc5
11/10/2024
06:05
Winter is coming. The bulletin board's bears are hibernating.
obiterdicta
10/10/2024
21:41
Thanks for the insight there bones...bodes well
gleach23
10/10/2024
19:32
bones I really hope so !!
parsons4
10/10/2024
18:40
At one point today the MM’s were bidding for up to 375,000 shares at 14.2p on a retail platform (when spread was 13.5-15.0). That’s very unusual. You could buy virtually nothing online.

Another source reported that to buy 220k would set you back 16.5p and double that number would cost 18p (on the RSP platform that institutions and brokers use).

Got to hope the company can follow up with more positive developments.

bones
10/10/2024
16:51
After seeing the small buys at full price I did some dummy trades and noticed hardly any shares available to buy. Then the 111,692 shares trade @ 14.89p was reported 2 hours late to explain it.

Hopefully a sign of retail sellers having been mopped up and that any further buying will put upwards pressure on the share price

The recent chart certainly has a promising look to it.

gleach23
10/10/2024
16:44
Quietly firm !! still waiting for a positive RNS in relation to the heart valve business next !
parsons4
03/10/2024
22:16
Reminder of the prices Directors/Insiders paid in recent years

Directors Deals for Rua Life Sci. (RUA)

Announced Traded Action Notifier Price
14-Dec-22 14-Dec-22 Buy Lachlan Smith 54.17

30-Dec-20 30-Dec-20 Placing Geoffrey Alan Berg 120.00

30-Dec-20 30-Dec-20 Placing John Louis Ely 120.00

thiopia
03/10/2024
21:16
Escape Velocity is a very good way of terming it. You can see from the trajectory and the 'resistance levels' evident in this chart that we are approaching breaking out of the 'atmosphere' and into big spaces where the chart has gapped up and down a lot
thiopia
03/10/2024
20:40
The board's bears hibernating?Or in denial?Unable to admit RUA is a value story - cct manufacturing.And a growth story, the rest.15p is still cheap. But some let ego unable to admit they made a bad call.
obiterdicta
03/10/2024
18:34
Big volume on the up days.
Yesterday’s down candle completely “engulfed̶1; by a strong up candle with volume.
Breakout through months of resistance at 13 with two closes above that.

All points to a positive technical picture.

On the fundamentals, it’s about time the market recognised the recent acquisition of ABISS and its potential to double turnover and add to profitability, on top of the additional £700k of turnover highlighted in Contract Manufacturing with the one off contract that they hope to convert to an additional longer term contract.

Millions of shares have been sold in the recent few months in the 10p - 11p region and they are likely to have cause to regret their impatience. I hope RUA can achieve some kind of escape velocity this time around. Securing some kind of agreement following the MTA would be a great help too!

bones
01/10/2024
09:48
NickE

Today 09:55

Posts: 659

Price: 14.25

They have moved off NT now. Hate to tempt fate but it does look like the main seller is out now and their presence has meant the recent advances and future prospects for the Company hasn't been reflected in the share price.

So it's catch up time along with the prospect of both value enhancing news (due diligence on the acquisition, further contracts for contract manufacturing) and potential transformational news - some form of deal on AurTex whether it be licensing or an outright sale of Structural Heart or the whole .

The latter would quite probably take the share price into 3 figures. Nice risk reward given the seemingly positive strides towards profitability for the group as a whole and a mere 8.4m m/cap.

The management seems driven in their efforts to reach profitability which has meant the stock is a bit of a hidden gem - partly because part of that effort has included cutting costs including not renewing the pr contract with Equity Development

thiopia
01/10/2024
08:47
The m/cap here is still only £8.4m, yet RUA has well over a £3m+ cash pile and likely £5m+ revenues post the Abiss acquisition, together with blue sky operations in the price for very little and forecast £0.4m PBT profitability pre-Abiss to March'26.

Loads to play for here imho assuming no hiccups.

rivaldo
30/9/2024
17:01
Nice chart
Nice candle

thiopia
30/9/2024
15:07
They'll be some upgrades coming. £80k and a doubling of annual revenues.Bit of fine tuning they could churn some cash out Then the heart valve wildcard on top ....20p should be base
mikeh30
30/9/2024
15:02
It's all in the RNS, but no - not massive debts. Some French Govt Covid support loans to pay back and a bit more, but nothing they can't handle. A complete bargain.
verulamium
30/9/2024
14:53
Would you acquire a Co. with lot of debts? Ehhh...
4vik
Chat Pages: 151  150  149  148  147  146  145  144  143  142  141  140  Older

Your Recent History

Delayed Upgrade Clock